Immix Biopharma, Inc. (IMMX) vs Lexicon Pharmaceuticals, Inc. (LXRX)
- Immix Biopharma, Inc. IMMX 7.98 −8.06%
- Lexicon Pharmaceuticals, Inc. LXRX 1.52 −7.88%
Immix Biopharma, Inc. and Lexicon Pharmaceuticals, Inc. are both Biotechnology companies. Immix Biopharma, Inc. and Lexicon Pharmaceuticals, Inc. are of similar size ($734.2M and $719.6M). Immix Biopharma, Inc. has the higher net margin (0.00% vs −147.4%) and the higher return on invested capital (0.00% vs −96.4%). Across the 13 metrics below, Immix Biopharma, Inc. leads on 9 and Lexicon Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | IMMX | LXRX | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 99.14% | 65.16% |
| Operating margin | 0.00% | (131.43%) | 0.00% |
| Net margin | 0.00% | (147.38%) | 0.00% |
| Free cash flow margin | 0.00% | (156.71%) | 0.00% |
| Return on equity | (34.18%) | (40.21%) | (56.36%) |
| Return on assets | (31.34%) | (25.70%) | (48.04%) |
| Return on invested capital | 0.00% | (96.36%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack